Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice.

Bone Rep · 2020 · PMC7305378 · PMID 32577437

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

By contrast, the increase in BV/TV did not reach statistical significance after 4 weeks of BP treatment compared with that in the OVX group but was higher, especially in proximal tibia, 4 weeks after discontinuation.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.